Elective coronary revascularization, an iatrogenic form of acute coronary syndrome: how can clinicians reduce the risks?
Mukherjee
Debabrata
D
Division of Cardiology, University of Michigan, Ann Arbor, Mich, USA.
Oz
Mehmet
M
Prager
Richard
R
Eagle
Kim A
KA
D000208:Acute Disease; D015906:Angioplasty, Balloon, Coronary; D015415:Biomarkers / Q000097:blood; D003327:Coronary Disease / Q000097:blood / Q000628:therapy*; D003402:Creatine Kinase / Q000097:blood*; D052279:Creatine Kinase, MB Form; D017558:Elective Surgical Procedures; D006801:Humans; D007049:Iatrogenic Disease; D007527:Isoenzymes / Q000097:blood*; D017202:Myocardial Ischemia / Q000097:blood / Q000209:etiology* / Q000628:therapy; D009204:Myocardial Revascularization / Q000009:adverse effects*; D011379:Prognosis; D012306:Risk; D014336:Troponin / Q000097:blood*
D015415:Biomarkers; D007527:Isoenzymes; D014336:Troponin; D003402:Creatine Kinase; D052279:Creatine Kinase, MB Form